期刊文献+

老年心房颤动患者脑缺血发生与血清脂蛋白(a)水平的关系研究

Relationship between cerebral ischemia and serum level of lipoprotein(a) in old people with chronic atrial fibrillation
原文传递
导出
摘要 目的 :探讨老年慢性心房颤动 (AF)患者脑缺血发生 (包括短暂性脑缺血发作及脑梗死或脑栓塞 )与血清脂蛋白 (a) [LP(a) ]浓度之间的关系。方法 :无脑缺血发生的慢性AF患者 70例 ,3个月以内曾出现脑缺血发作的慢性AF患者 6 2例 ,另选取有器质性心脑血管病但无AF的患者 6 4例作为对照组。采用酶联免疫吸附法(ELISA)测定LP(a)水平。结果 :脑缺血发生组LP(a)浓度显著高于无脑缺血发生组及对照组 (P <0 .0 5 ,P <0 .0 1) ,而无脑缺血发生组与对照组之间差异无统计学意义 (P >0 .0 5 )。结论 :老年慢性AF患者血清LP(a)浓度升高可能是导致脑缺血发作的原因之一。 Objective:To investigate relationship between occurrence of cerebral ischemia(including transient ischemic attack, cerebral infarction and cerebral embolism) and level of lipoprotein(a) [Lp(a)]in old people with chronic atrial fibrillation(AF). Method:The level of LP(a) was detected by enzyme-linked immunosorbent assay(ELISA) in 132 patients with chronic AF and in 64 control cases. The AF patients were divided into a group of 70 patients with cerebral ischemia occurred recently and a group of 62 patients without cerebral ischemia recently, and a group of 64 patients with organic cardiovascular or cerebrovascular diseases but without AF was control group. Result:The concentrations of LP(a) was significantly higher in the cerebral-ischemia group than that of the non -cerebral-ischemia group and control group. However, there was no difference between the non- cerebral-ischemia group and control group. Conclution: Increase of LP(a) in older patients with chronic AF may be one of the important factors for occurence of cerebral ischemia.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2004年第10期584-585,共2页 Journal of Clinical Cardiology
关键词 患者 脑缺血 LP(a) 老年 血清脂蛋白(a) 对照组 慢性 水平 Atrial fibrillation Cerebral ischemia Lipoprotein(a)
  • 相关文献

参考文献7

  • 1Kitchin A H, Milne J S. Longitudinal survey of ischemic heart disease in a randomly selected sample of older population. Br Heart J,1997,39:889-893.
  • 2Levy S, Breithardt G, Campbell R W F, et al. On behalf of the working group on arrhythmial of the Europe an society of cardiology. Artial fibrillation; current knowledge and recommendations for management. Eur Heart J,1998,19:1294-1320.
  • 3Prystowsky E N, Benson J D, Woodrow M D, et al.Management of patients with atrial fibrillation: a state ment for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation, 1996,93:
  • 4Cabin H S. Clubb K S, Hall C, et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol,1990, 61:714-717.
  • 5Sirikci O, Aytekin V, Demiroglu I C, et al. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty. Int J Clin Lab Res, 2000,30: 93- 99.
  • 6Igarashi Y, Yamaura M, Breithardt G, et al. Elevated serum LP(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophaged echocardio-graphic study. Am Heart J, 1998,136:965-971.
  • 7Torbus L B, Bukowska H, Jastrzebska M, et al. LP (a), homocysteine and a family history of early ischemic cerebral stroke. Nutr Metab Cardiovasc Dis, 2001, 11(S5) :52-59.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部